Single-blinded randomized trial of Botulinumtoxin A (Vistabel®) and its objective paralytic effect in the facial muscles of healthy women: development of new neurophysiological measurements. - Glabellar neurophysiology upon BoNT injection

ppsala University Hospital0 个研究点目标入组 16 人开始时间: 2011年10月6日最近更新: 2020年5月25日

适应症

试验速览

暂无简介。

•Healthy women in the age of 30-64 years of age (not yet 65 years). Visible glabellar lines. Motivated to participate in the clinical trial without any economical compensation. Filled in the informed consent.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 16
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•Clinical or subclinical neuromuscular disorder/symptoms. Allergy towards the BoNT which will be used or other component. Previous injections of BoNT or plastic surgery in the facial region. Implants in the glabellar region. Ongoing infection, systemic disease or inflammation around the muscles to be injected. Earlier unspecified severe allergic reactions. Known coagulation deficit or anticoagulantia. Medication with anticholinergic or muscle relaxing agents. Pregnancy or lactation.

发起方

ppsala University Hospital